Skip to main content
Caplight Logo









Papilio.bio

Papilio.bio

Private
ParisHealthcare & Life Scienceshttps://papilio.bio/

Last Round

Accelerator

Oct 8, 2024

Total Funding Raised

$30,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Papilio.bio is a medtech company developing a rapid at-home molecular self-test and companion app for HPV detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Telemedicine, Precision Medicine

Business Model

B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

HPV self-testat-home diagnosticsat-home testingmolecular diagnosticsHPVcervical cancer screeninghuman papillomaviruslateral flow testSTI testingtelehealthpoint-of-care diagnosticsPOC testingbiomarker detectiondigital companion appdirect-to-consumer diagnosticsfemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Papilio.bio Comparables

Compare Papilio.bio with similar companies based on industry and business-model similarity.

Papilio.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Teal Health
80%
Thyia
77%
Ziel Biosciences
75%

Papilio.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 8, 2024

Key People

Founding team and executive leadership

Chiara Cespi Polisiani

CEO & Co-founder

Founding Team

Papilio.bio Investors

Notable investors and investment history

Papilio.bio investors
InvestorRounds
GenopoleAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 504% MoM.

  • Oct 8, 2024

    $20K raised from Genopole

Papilio.bio Filings

Explore SEC and related filing metadata, where available.

Papilio.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Papilio.bio's valuation, stock price, and market status.

Is Papilio.bio a public or private company?

Papilio.bio is a private company.

What is the current stock price of Papilio.bio?

Papilio.bio is a private company with no public stock price. Caplight tracks Papilio.bio's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Papilio.bio worth (valuation)?

Valuation information for Papilio.bio is not publicly available.

Can I buy Papilio.bio stock?

Papilio.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Papilio.bio's last funding round?

Papilio.bio's most recent funding round was Accelerator on October 8, 2024.

Who are the main investors in Papilio.bio?

Key investors in Papilio.bio include Genopole.

Will Papilio.bio IPO soon?

No public IPO plans have been announced for Papilio.bio.

How can I track Papilio.bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Papilio.bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range3
Year Founded2024
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?